Diovan

AHA: Impact of Valsartan Recall Examined for Ontario, Canada

AHA: Impact of Valsartan Recall Examined for Ontario, Canada

Physician’s Briefing Staff

Nov 18, 2019

2 min read

FDA: Risk From Tainted Blood Pressure Drugs Very Low

Cardiovascular Diseases

FDA: Risk From Tainted Blood Pressure Drugs Very Low

Physician’s Briefing Staff

Aug 29, 2019

1 min read

FDA Approves New Generic Valsartan to Ease Shortage

Cardiovascular Diseases

FDA Approves New Generic Valsartan to Ease Shortage

Physician’s Briefing Staff

Mar 13, 2019

1 min read

Teva Recalls Two Blood Pressure Medications

Cardiovascular Diseases

Teva Recalls Two Blood Pressure Medications

Physician’s Briefing Staff

Nov 30, 2018

1 min read

FDA Finds Another Carcinogen in Certain Valsartan Heart Meds

Cardiovascular Diseases

FDA Finds Another Carcinogen in Certain Valsartan Heart Meds

Physician’s Briefing Staff

Sep 14, 2018

1 min read

No Apparent Short-Term Cancer Risk From Recalled Valsartan

Cardiovascular Diseases

No Apparent Short-Term Cancer Risk From Recalled Valsartan

Physician’s Briefing Staff

Sep 13, 2018

1 min read

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

Physician’s Briefing Staff

Jul 19, 2018

1 min read

www.healthday.com